164 related articles for article (PubMed ID: 11835398)
1. Phytoestrogen genistein stimulates the production of osteoprotegerin by human trabecular osteoblasts.
Viereck V; Gründker C; Blaschke S; Siggelkow H; Emons G; Hofbauer LC
J Cell Biochem; 2002; 84(4):725-35. PubMed ID: 11835398
[TBL] [Abstract][Full Text] [Related]
2. Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts.
Viereck V; Gründker C; Blaschke S; Niederkleine B; Siggelkow H; Frosch KH; Raddatz D; Emons G; Hofbauer LC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4206-13. PubMed ID: 12970288
[TBL] [Abstract][Full Text] [Related]
3. Isopropanolic extract of black cohosh stimulates osteoprotegerin production by human osteoblasts.
Viereck V; Gründker C; Friess SC; Frosch KH; Raddatz D; Schoppet M; Nisslein T; Emons G; Hofbauer LC
J Bone Miner Res; 2005 Nov; 20(11):2036-43. PubMed ID: 16234977
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.
Viereck V; Emons G; Lauck V; Frosch KH; Blaschke S; Gründker C; Hofbauer LC
Biochem Biophys Res Commun; 2002 Mar; 291(3):680-6. PubMed ID: 11855844
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene.
Cheung J; Mak YT; Papaioannou S; Evans BA; Fogelman I; Hampson G
J Endocrinol; 2003 Jun; 177(3):423-33. PubMed ID: 12773123
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis.
Hofbauer LC; Gori F; Riggs BL; Lacey DL; Dunstan CR; Spelsberg TC; Khosla S
Endocrinology; 1999 Oct; 140(10):4382-9. PubMed ID: 10499489
[TBL] [Abstract][Full Text] [Related]
7. Genistein modulates the effects of parathyroid hormone in human osteoblastic SaOS-2 cells.
Chen WF; Wong MS
Br J Nutr; 2006 Jun; 95(6):1039-47. PubMed ID: 16768824
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts.
Viereck V; Gründker C; Blaschke S; Frosch KH; Schoppet M; Emons G; Hofbauer LC
J Cell Biochem; 2005 Dec; 96(6):1244-53. PubMed ID: 16152630
[TBL] [Abstract][Full Text] [Related]
9. The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts.
Bord S; Ireland DC; Beavan SR; Compston JE
Bone; 2003 Feb; 32(2):136-41. PubMed ID: 12633785
[TBL] [Abstract][Full Text] [Related]
10. Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells.
Hofbauer LC; Khosla S; Dunstan CR; Lacey DL; Spelsberg TC; Riggs BL
Endocrinology; 1999 Sep; 140(9):4367-70. PubMed ID: 10465311
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
12. Estrogen specifically stimulates expression and production of osteoprotegerin from rheumatoid synovial fibroblasts.
Mitani M; Miura Y; Saura R; Kitagawa A; Fukuyama T; Hashiramoto A; Shiozawa S; Kurosaka M; Yoshiya S
Int J Mol Med; 2005 May; 15(5):827-32. PubMed ID: 15806305
[TBL] [Abstract][Full Text] [Related]
13. Regulation of osteoprotegerin production by androgens and anti-androgens in human osteoblastic lineage cells.
Hofbauer LC; Hicok KC; Chen D; Khosla S
Eur J Endocrinol; 2002 Aug; 147(2):269-73. PubMed ID: 12153751
[TBL] [Abstract][Full Text] [Related]
14. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae.
Palmqvist P; Persson E; Conaway HH; Lerner UH
J Immunol; 2002 Sep; 169(6):3353-62. PubMed ID: 12218157
[TBL] [Abstract][Full Text] [Related]
15. Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.
Humphrey EL; Williams JH; Davie MW; Marshall MJ
Bone; 2006 May; 38(5):652-61. PubMed ID: 16298558
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
[TBL] [Abstract][Full Text] [Related]
17. Effects of genistein on expression of bone markers during MC3T3-E1 osteoblastic cell differentiation.
Chen X; Garner SC; Quarles LD; Anderson JJ
J Nutr Biochem; 2003 Jun; 14(6):342-9. PubMed ID: 12873716
[TBL] [Abstract][Full Text] [Related]
18. Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation.
Suda K; Udagawa N; Sato N; Takami M; Itoh K; Woo JT; Takahashi N; Nagai K
J Immunol; 2004 Feb; 172(4):2504-10. PubMed ID: 14764723
[TBL] [Abstract][Full Text] [Related]
19. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
20. Increased OPG/RANKL ratio in the conditioned medium of soybean-treated osteoblasts suppresses RANKL-induced osteoclast differentiation.
Park K; Ju WC; Yeo JH; Kim JY; Seo HS; Uchida Y; Cho Y
Int J Mol Med; 2014 Jan; 33(1):178-84. PubMed ID: 24248634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]